Cargando…
TNF-alpha inhibition ameliorates HDV-induced liver damage in a mouse model of acute severe infection
BACKGROUND & AIMS: HDV infection induces the most severe form of human viral hepatitis. However, the specific reasons for the severity of the disease remain unknown. Recently, we developed an HDV replication mouse model in which, for the first time, liver damage was detected. METHODS: HDV and HB...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200939/ https://www.ncbi.nlm.nih.gov/pubmed/32382723 http://dx.doi.org/10.1016/j.jhepr.2020.100098 |
_version_ | 1783529441968783360 |
---|---|
author | Usai, Carla Maestro, Sheila Camps, Gracian Olague, Cristina Suárez-Amaran, Lester Vales, Africa Aragon, Tomas Hommel, Mirja Aldabe, Rafael Gonzalez-Aseguinolaza, Gloria |
author_facet | Usai, Carla Maestro, Sheila Camps, Gracian Olague, Cristina Suárez-Amaran, Lester Vales, Africa Aragon, Tomas Hommel, Mirja Aldabe, Rafael Gonzalez-Aseguinolaza, Gloria |
author_sort | Usai, Carla |
collection | PubMed |
description | BACKGROUND & AIMS: HDV infection induces the most severe form of human viral hepatitis. However, the specific reasons for the severity of the disease remain unknown. Recently, we developed an HDV replication mouse model in which, for the first time, liver damage was detected. METHODS: HDV and HBV replication-competent genomes and HDV antigens were delivered to mouse hepatocytes using adeno-associated vectors (AAVs). Aminotransferase elevation, liver histopathology, and hepatocyte death were evaluated and the immune infiltrate was characterized. Liver transcriptomic analysis was performed. Mice deficient for different cellular and molecular components of the immune system, as well as depletion and inhibition studies, were employed to elucidate the causes of HDV-mediated liver damage. RESULTS: AAV-mediated HBV/HDV coinfection caused hepatocyte necrosis and apoptosis. Activated T lymphocytes, natural killer cells, and proinflammatory macrophages accounted for the majority of the inflammatory infiltrate. However, depletion studies and the use of different knockout mice indicated that neither T cells, natural killer cells nor macrophages were necessary for HDV-induced liver damage. Transcriptomic analysis revealed a strong activation of type I and II interferon (IFN) and tumor necrosis factor (TNF)-α pathways in HBV/HDV-coinfected mice. While the absence of IFN signaling had no effect, the use of a TNF-α antagonist resulted in a significant reduction of HDV-associated liver injury. Furthermore, hepatic expression of HDAg resulted in the induction of severe liver damage, which was T cell- and TNF-α-independent. CONCLUSIONS: Both host (TNF-α) and viral (HDV antigens) factors play a relevant role in HDV-induced liver damage. Importantly, pharmacological inhibition of TNF-α may offer an attractive strategy to aid control of HDV-induced acute liver damage. LAY SUMMARY: Chronic hepatitis delta constitutes the most severe form of viral hepatitis. There is limited data on the mechanism involved in hepatitis delta virus (HDV)-induced liver pathology. Our data indicate that a cytokine (TNF-α) and HDV antigens play a relevant role in HDV-induced liver damage. |
format | Online Article Text |
id | pubmed-7200939 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-72009392020-05-07 TNF-alpha inhibition ameliorates HDV-induced liver damage in a mouse model of acute severe infection Usai, Carla Maestro, Sheila Camps, Gracian Olague, Cristina Suárez-Amaran, Lester Vales, Africa Aragon, Tomas Hommel, Mirja Aldabe, Rafael Gonzalez-Aseguinolaza, Gloria JHEP Rep Research Article BACKGROUND & AIMS: HDV infection induces the most severe form of human viral hepatitis. However, the specific reasons for the severity of the disease remain unknown. Recently, we developed an HDV replication mouse model in which, for the first time, liver damage was detected. METHODS: HDV and HBV replication-competent genomes and HDV antigens were delivered to mouse hepatocytes using adeno-associated vectors (AAVs). Aminotransferase elevation, liver histopathology, and hepatocyte death were evaluated and the immune infiltrate was characterized. Liver transcriptomic analysis was performed. Mice deficient for different cellular and molecular components of the immune system, as well as depletion and inhibition studies, were employed to elucidate the causes of HDV-mediated liver damage. RESULTS: AAV-mediated HBV/HDV coinfection caused hepatocyte necrosis and apoptosis. Activated T lymphocytes, natural killer cells, and proinflammatory macrophages accounted for the majority of the inflammatory infiltrate. However, depletion studies and the use of different knockout mice indicated that neither T cells, natural killer cells nor macrophages were necessary for HDV-induced liver damage. Transcriptomic analysis revealed a strong activation of type I and II interferon (IFN) and tumor necrosis factor (TNF)-α pathways in HBV/HDV-coinfected mice. While the absence of IFN signaling had no effect, the use of a TNF-α antagonist resulted in a significant reduction of HDV-associated liver injury. Furthermore, hepatic expression of HDAg resulted in the induction of severe liver damage, which was T cell- and TNF-α-independent. CONCLUSIONS: Both host (TNF-α) and viral (HDV antigens) factors play a relevant role in HDV-induced liver damage. Importantly, pharmacological inhibition of TNF-α may offer an attractive strategy to aid control of HDV-induced acute liver damage. LAY SUMMARY: Chronic hepatitis delta constitutes the most severe form of viral hepatitis. There is limited data on the mechanism involved in hepatitis delta virus (HDV)-induced liver pathology. Our data indicate that a cytokine (TNF-α) and HDV antigens play a relevant role in HDV-induced liver damage. Elsevier 2020-03-10 /pmc/articles/PMC7200939/ /pubmed/32382723 http://dx.doi.org/10.1016/j.jhepr.2020.100098 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Article Usai, Carla Maestro, Sheila Camps, Gracian Olague, Cristina Suárez-Amaran, Lester Vales, Africa Aragon, Tomas Hommel, Mirja Aldabe, Rafael Gonzalez-Aseguinolaza, Gloria TNF-alpha inhibition ameliorates HDV-induced liver damage in a mouse model of acute severe infection |
title | TNF-alpha inhibition ameliorates HDV-induced liver damage in a mouse model of acute severe infection |
title_full | TNF-alpha inhibition ameliorates HDV-induced liver damage in a mouse model of acute severe infection |
title_fullStr | TNF-alpha inhibition ameliorates HDV-induced liver damage in a mouse model of acute severe infection |
title_full_unstemmed | TNF-alpha inhibition ameliorates HDV-induced liver damage in a mouse model of acute severe infection |
title_short | TNF-alpha inhibition ameliorates HDV-induced liver damage in a mouse model of acute severe infection |
title_sort | tnf-alpha inhibition ameliorates hdv-induced liver damage in a mouse model of acute severe infection |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200939/ https://www.ncbi.nlm.nih.gov/pubmed/32382723 http://dx.doi.org/10.1016/j.jhepr.2020.100098 |
work_keys_str_mv | AT usaicarla tnfalphainhibitionameliorateshdvinducedliverdamageinamousemodelofacutesevereinfection AT maestrosheila tnfalphainhibitionameliorateshdvinducedliverdamageinamousemodelofacutesevereinfection AT campsgracian tnfalphainhibitionameliorateshdvinducedliverdamageinamousemodelofacutesevereinfection AT olaguecristina tnfalphainhibitionameliorateshdvinducedliverdamageinamousemodelofacutesevereinfection AT suarezamaranlester tnfalphainhibitionameliorateshdvinducedliverdamageinamousemodelofacutesevereinfection AT valesafrica tnfalphainhibitionameliorateshdvinducedliverdamageinamousemodelofacutesevereinfection AT aragontomas tnfalphainhibitionameliorateshdvinducedliverdamageinamousemodelofacutesevereinfection AT hommelmirja tnfalphainhibitionameliorateshdvinducedliverdamageinamousemodelofacutesevereinfection AT aldaberafael tnfalphainhibitionameliorateshdvinducedliverdamageinamousemodelofacutesevereinfection AT gonzalezaseguinolazagloria tnfalphainhibitionameliorateshdvinducedliverdamageinamousemodelofacutesevereinfection |